The world is desperate for weight-loss drugs, but pharmaceutical companies face strict laws on advertising these medications. In Britain, companies like Novo Nordisk are banned from advertising medications that can only be prescribed by a doctor.
Regulations on Advertising
In the United States, it’s a different story. The First Amendment to the US Constitution restricts the American government from regulating most kinds of speech, allowing pharmaceutical companies to advertise their products. However, health agencies in the US are cracking down on online pharmacies’ promotion of weight-loss drugs.
Novo Nordisk, the maker of Ozempic and Wegovy, recently ran a disease awareness campaign in London. The campaign aimed to encourage people to understand obesity as a complex, chronic health condition. However, the company is not allowed to promote its specific medications in the campaign.
In France, both Novo Nordisk and its American rival Eli Lilly have fallen afoul of advertising rules. The companies were fined for public campaigns that were considered to be indirect promotions of prescription-only drugs.
Original reporting: KEYT (Ventura/Santa Barbara) — read the source article.
